Computational drug discovery approach based on nuclear factor-κB pathway dynamics

Ky Youb Nam, Won Seok Oh, Chul Kim, Miyoung Song, Jong Young Joung, Sunyoung Kim, Jaeseong Park, Sin Moon Gang, Young Uk Cho, Kyoung Tai No

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The NF-κB system of transcription factors plays a crucial role in inflammatory diseases, making it an important drug target. We combined quantitative structure activity relationships for predicting the activity of new compounds and quantitative dynamic models for the NF-κB network with intracellular concentration models. GFA-MLR QSAR analysis was employed to determine the optimal QSAR equation. To validate the predictability of the IKKb QSAR model for an external set of inhibitors, a set of ordinary differential equations and mass action kinetics were used for modeling the NF-κB dynamic system. The reaction parameters were obtained from previously reported research. In the IKKb QSAR model, good cross-validated q 2 (0.782) and conventional r 2 (0.808) values demonstrated the correlation between the descriptors and each of their activities and reliably predicted the IKKβ activities. Using a developed simulation model of the NF-κB signaling pathway, we demonstrated differences in IκB mRNA expression between normal and different inhibitory states. When the inhibition efficiency increased, inhibitor 1 (PS-1145) led to long-term oscillations. The combined computational modeling and NF-κB dynamic simulations can be used to understand the inhibition mechanisms and thereby result in the design of mechanism-based inhibitors.

Original languageEnglish
Pages (from-to)4397-4402
Number of pages6
JournalBulletin of the Korean Chemical Society
Volume32
Issue number12
DOIs
Publication statusPublished - 2011 Dec 20

Fingerprint

Ordinary differential equations
Dynamic models
Dynamical systems
Transcription Factors
Messenger RNA
Kinetics
Drug Discovery
Computer simulation
Pharmaceutical Preparations
PS1145

All Science Journal Classification (ASJC) codes

  • Chemistry(all)

Cite this

Nam, Ky Youb ; Oh, Won Seok ; Kim, Chul ; Song, Miyoung ; Joung, Jong Young ; Kim, Sunyoung ; Park, Jaeseong ; Gang, Sin Moon ; Cho, Young Uk ; No, Kyoung Tai. / Computational drug discovery approach based on nuclear factor-κB pathway dynamics. In: Bulletin of the Korean Chemical Society. 2011 ; Vol. 32, No. 12. pp. 4397-4402.
@article{b2ddbd091e19418ebbd15786bb22622b,
title = "Computational drug discovery approach based on nuclear factor-κB pathway dynamics",
abstract = "The NF-κB system of transcription factors plays a crucial role in inflammatory diseases, making it an important drug target. We combined quantitative structure activity relationships for predicting the activity of new compounds and quantitative dynamic models for the NF-κB network with intracellular concentration models. GFA-MLR QSAR analysis was employed to determine the optimal QSAR equation. To validate the predictability of the IKKb QSAR model for an external set of inhibitors, a set of ordinary differential equations and mass action kinetics were used for modeling the NF-κB dynamic system. The reaction parameters were obtained from previously reported research. In the IKKb QSAR model, good cross-validated q 2 (0.782) and conventional r 2 (0.808) values demonstrated the correlation between the descriptors and each of their activities and reliably predicted the IKKβ activities. Using a developed simulation model of the NF-κB signaling pathway, we demonstrated differences in IκB mRNA expression between normal and different inhibitory states. When the inhibition efficiency increased, inhibitor 1 (PS-1145) led to long-term oscillations. The combined computational modeling and NF-κB dynamic simulations can be used to understand the inhibition mechanisms and thereby result in the design of mechanism-based inhibitors.",
author = "Nam, {Ky Youb} and Oh, {Won Seok} and Chul Kim and Miyoung Song and Joung, {Jong Young} and Sunyoung Kim and Jaeseong Park and Gang, {Sin Moon} and Cho, {Young Uk} and No, {Kyoung Tai}",
year = "2011",
month = "12",
day = "20",
doi = "10.5012/bkcs.2011.32.12.4397",
language = "English",
volume = "32",
pages = "4397--4402",
journal = "Bulletin of the Korean Chemical Society",
issn = "0253-2964",
publisher = "Korean Chemical Society",
number = "12",

}

Nam, KY, Oh, WS, Kim, C, Song, M, Joung, JY, Kim, S, Park, J, Gang, SM, Cho, YU & No, KT 2011, 'Computational drug discovery approach based on nuclear factor-κB pathway dynamics', Bulletin of the Korean Chemical Society, vol. 32, no. 12, pp. 4397-4402. https://doi.org/10.5012/bkcs.2011.32.12.4397

Computational drug discovery approach based on nuclear factor-κB pathway dynamics. / Nam, Ky Youb; Oh, Won Seok; Kim, Chul; Song, Miyoung; Joung, Jong Young; Kim, Sunyoung; Park, Jaeseong; Gang, Sin Moon; Cho, Young Uk; No, Kyoung Tai.

In: Bulletin of the Korean Chemical Society, Vol. 32, No. 12, 20.12.2011, p. 4397-4402.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Computational drug discovery approach based on nuclear factor-κB pathway dynamics

AU - Nam, Ky Youb

AU - Oh, Won Seok

AU - Kim, Chul

AU - Song, Miyoung

AU - Joung, Jong Young

AU - Kim, Sunyoung

AU - Park, Jaeseong

AU - Gang, Sin Moon

AU - Cho, Young Uk

AU - No, Kyoung Tai

PY - 2011/12/20

Y1 - 2011/12/20

N2 - The NF-κB system of transcription factors plays a crucial role in inflammatory diseases, making it an important drug target. We combined quantitative structure activity relationships for predicting the activity of new compounds and quantitative dynamic models for the NF-κB network with intracellular concentration models. GFA-MLR QSAR analysis was employed to determine the optimal QSAR equation. To validate the predictability of the IKKb QSAR model for an external set of inhibitors, a set of ordinary differential equations and mass action kinetics were used for modeling the NF-κB dynamic system. The reaction parameters were obtained from previously reported research. In the IKKb QSAR model, good cross-validated q 2 (0.782) and conventional r 2 (0.808) values demonstrated the correlation between the descriptors and each of their activities and reliably predicted the IKKβ activities. Using a developed simulation model of the NF-κB signaling pathway, we demonstrated differences in IκB mRNA expression between normal and different inhibitory states. When the inhibition efficiency increased, inhibitor 1 (PS-1145) led to long-term oscillations. The combined computational modeling and NF-κB dynamic simulations can be used to understand the inhibition mechanisms and thereby result in the design of mechanism-based inhibitors.

AB - The NF-κB system of transcription factors plays a crucial role in inflammatory diseases, making it an important drug target. We combined quantitative structure activity relationships for predicting the activity of new compounds and quantitative dynamic models for the NF-κB network with intracellular concentration models. GFA-MLR QSAR analysis was employed to determine the optimal QSAR equation. To validate the predictability of the IKKb QSAR model for an external set of inhibitors, a set of ordinary differential equations and mass action kinetics were used for modeling the NF-κB dynamic system. The reaction parameters were obtained from previously reported research. In the IKKb QSAR model, good cross-validated q 2 (0.782) and conventional r 2 (0.808) values demonstrated the correlation between the descriptors and each of their activities and reliably predicted the IKKβ activities. Using a developed simulation model of the NF-κB signaling pathway, we demonstrated differences in IκB mRNA expression between normal and different inhibitory states. When the inhibition efficiency increased, inhibitor 1 (PS-1145) led to long-term oscillations. The combined computational modeling and NF-κB dynamic simulations can be used to understand the inhibition mechanisms and thereby result in the design of mechanism-based inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=84255189731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84255189731&partnerID=8YFLogxK

U2 - 10.5012/bkcs.2011.32.12.4397

DO - 10.5012/bkcs.2011.32.12.4397

M3 - Article

VL - 32

SP - 4397

EP - 4402

JO - Bulletin of the Korean Chemical Society

JF - Bulletin of the Korean Chemical Society

SN - 0253-2964

IS - 12

ER -